A pioneering procedure is showcasing the future of medicine. UC Health performed the region's first fully robotic heart procedure.

A 27-year-old woman underwent a successful robot-assisted mitral valve repair at Apollo Hospitals Bannerghatta, showcasing the growing popularity of minimally invasive cardiac surgery. This advanced ...

Stereotaxis is pushing the positives of its robotic magnetic navigation systems, MAGiC cardiac catheters and EMAGIN ...

Successfully treated atrial fibrillation (AF) in initial 30 patients with the nPulse Cardiac Surgical System Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse technology ...

Pulse Biosciences PLSE recently reported encouraging late-breaking data from the first-in-human feasibility study of its ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the ...

PRINCETON, N.J., Sept. 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using ...

Pulse Biosciences Inc. presented late-breaking results from its successful first-in-human study of its nanosecond pulsed ...

We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. Pulse Biosciences, Inc. is one of them. Pulse Biosciences, Inc. (NASDAQ:PLSE) is advancing bioelectric medicine ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced ...

Pulse Biosciences (Nasdaq:PLSE) today announced clinical study results from a first-in-human study of its nPulse system.

Dr. Greg Hundley: Yes, Peder, let's go. Dr. Peder Myhre: ...